Back

Transforming growth factor beta and fibroblast growth factor 21 in cardiovascular prognosis in patients with obesity and type 2 diabetes mellitus

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Diabetes Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Teona Shvangiradze

Endocrinology Research Center, Moscow (Russian Federation)

14 More presentations in this session

Presentation thumbnail
Absence of QTc prolongation with semaglutide: a thorough QT/QTc study in healthy subjects.
Doctor V. Demmel (Munchen, DE)
Abstract Slides
Presentation thumbnail
One year clinical outcome of biodegradable polymer sirolimus eluting stent in diabetes mellitus patients: insight from the ULISSE registry.
Doctor C. Pivato (Milan, IT)
Abstract
Presentation thumbnail
Increased left ventricular mass in non-hypertensive patients admitted with a first myocardial infarction and dysglycaemia by an oral glucose tolerance test
Mr G. Pararajasingam (Svendborg, DK)
Abstract Slides
Presentation thumbnail
Serum c-reactive protein and urine albumin level associated with silent myocardial ischemia in patients with diabetes mellitus
Mr Y. Honda (Gotemba, JP)
Abstract
Presentation thumbnail
Single and combined effects of inflammatory markers on diabetes development; the mediating role of obesity: 10-year follow up of the ATTICA study
Professor D. Panagiotakos (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Diabetes

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources